Diseased Human Peripheral Blood Products, Hematological Cancer

Primary human cells, frozen
Hematological Cancer, Custom, Frozen

Primary Cells, Frozen

Custom
Catalog # 200-0404

Overview

Start immuno-oncology experiments confidently with a reliable supply of ethically sourced, custom-isolated frozen peripheral blood plasma and serum from donors diagnosed with a hematological cancer.

Primary human plasma is isolated from peripheral blood using centrifugation. Primary human serum is isolated from peripheral blood after coagulation and removal of the fibrin clot and blood cells. All frozen peripheral blood products are obtained from donors diagnosed with a hematological cancer using Institutional Review Board (IRB)-approved consent forms and protocols. Additional documentation to meet institutional requirements is available upon request. Acid-citrate-dextrose (ACD), acid-citrate-dextrose solution A (ACDA), citrate-phosphate-dextrose (CPD), citrate-phosphate-double-dextrose (CP2D), or citrate-phosphate-dextrose-adenine (CPDA) is added during collection as an anticoagulant.

Contact your local sales representative or Product & Scientific Support at techsupport@stemcell.com for donor specifications (BMI category, smoking status, ethnicity, etc.). Donors are screened for HIV-1, HIV-2, hepatitis B, and hepatitis C. Certain products are only available in select territories.

For more information, browse frequently asked questions (FAQs) on primary cells.
Subtype
Frozen
Species
Human
Cell and Tissue Source
Plasma, Serum
Area of Interest
Cancer, Drug Discovery and Toxicity Testing, Stem Cell Biology
Donor Status
Diseased

Scientific Resources

Product Documentation

Document Type Product Name Catalog # Lot # Language
Document Type
Product Information Sheet
Product Name
Hematological Cancer, Custom, Frozen
Catalog #
200-0404
Lot #
All
Language
English

Educational Materials (4)

Brochure
Human Primary Cells
Brochure
Tools for Cancer Research
Brochure
Tools For Your Immunology Research
Webinar
Identification of Stem Cells in Myeloid Malignancies - Opportunities for Discovery and Translation
58:45
Identification of Stem Cells in Myeloid Malignancies - Opportunities for Discovery and Translation

Contact STEMCELL Technologies

Our Customer Service, Sales, and Product and Scientific Support departments in North America are available between 6 am and 5 pm Pacific Time (9 am and 8 pm Eastern Time). One of our representatives will be happy to help you by telephone or email. Please complete the form to contact us by email. A representative will get back to you shortly.
  •  

StemCell Technologies Inc. and affiliates ("STEMCELL Technologies") does not share your email address with third parties. StemCell Technologies Inc. will use your email address to confirm your identity and send you newsletters, transaction-related emails, promotional and customer service emails in accordance with our privacy policy. You can change your email preferences at any time.